Latest Financial Outlook Updates News

Microba Life Sciences has voluntarily suspended trading of its shares from 5 June 2026, ahead of a material capital raise and an update on its path to break even, expected by 11 June.

Corporate Travel Management revises down its FY25 revenue outlook by 4%, citing tariff and economic uncertainties in North America and Asia, while strong client wins bolster confidence for FY26.